Nature Nanotechnology - July issue

How to harness nanomaterials’ potential while ensuring safety? See the article on key advances in new tools/approaches. Authors include Douglas Connect's Managing director Barry Hardy and Scientific Project Manager Lucian Farcal.

Engineered nanomaterials (ENMs) are already being deployed across many sectors and their potential, both economic and scientific, is vast.

But how can we best assess and ensure their safety? An article in the July issue of Nature Nanotechnology presents much-needed perspective on key advances in tools and approaches.

Managing Director of Douglas Connect, Barry Hardy, and Scientific Project Manager Lucian Farcal are among the international authors who pooled their knowledge on the subject.

ABSTRACT

Engineered nanomaterials (ENMs) have tremendous potential to produce beneficial technological impact in numerous sectors in society. Safety assessment is, of course, of paramount importance. However, the myriad variations of ENM properties makes the identification of specific features driving toxicity challenging. At the same time, reducing animal tests by introducing alternative and/or predictive in vitro and in silico methods has become a priority. It is important to embrace these new advances in the safety assessment of ENMs.

Indeed, remarkable progress has been made in recent years with respect to mechanism-based hazard assessment of ENMs, including systems biology approaches as well as high-throughput screening platforms, and new tools are also emerging in risk assessment and risk management for humans and the environment across the whole life-cycle of nano-enabled products. Here, we highlight some of the key advances in the hazard and risk assessment of ENMs.

About Edelweiss Connect

Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.

Tags

Latest Tweets

Edelweiss Connect (4 days ago)
@Vertexlabs_ "We specialize in AI, Machine Learning, and Deep Learning - all very data-centric. What we bring to th… https://t.co/TY4w850dbx
Edelweiss Connect (4 days ago)
We are proud to announce #SaferWorldbyDesign founding partners - Edelweiss Connect, Biopredic International, Eurosa… https://t.co/IUkD8FpUqb
Edelweiss Connect (4 days ago)
RT @LucianFarcal: How do you store and share the protocols on #nanomaterials #physicochemical #characterisation? Read about the newest rele…
Edelweiss Connect (5 days ago)
Making AI available to companies, large and small - CEO Tom Bell explains why @Vertexlabs_ is a founding member of… https://t.co/oj7y7jNqq0
Edelweiss Connect (2 weeks ago)
#SaferWorldbyDesign is a new solution-oriented, safety assessment framework to support the design of intelligent, s… https://t.co/Rv6BsS7HHb

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com